Medical Condition News

RSS

The YAI Network launches new website to support people with disabilities

The YAI Network (YAI), one of America’s foremost non-profit organizations devoted to creating hope and opportunity for people with developmental and learning disabilities and their families, announced today the introduction of a new Web site at www.yai.org. The new site provides visitors with a crisp and clear presentation of the organization’s mission and opportunities to engage with the network to support people with disabilities as well as access services and information.

22 Sep 2009

Georgia Power Foundation's Michael Anderson honored during the 2009 Community Impact Awards

Atlanta Falcons Defensive End Chauncey Davis recently honored Georgia Power Foundation's Michael Anderson, Aetna's Cynthia Follmer and Camp Kudzu- Georgia's largest camp for kids with diabetes, during the 2009 Community Impact Awards, at the Arthur Blank Family Office.

22 Sep 2009

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.

22 Sep 2009

Narrative exposure therapy is effective for traumatized survivors

A group of German investigators performed a controlled study on psychological help for Rwanda orphans of war. Twenty-six orphans (originally 27) who presented with posttraumatic stress disorder (PTSD) at first assessment continued to meet a PTSD DSM-IV diagnosis 6 months after their initial assessment.

22 Sep 2009

French multicenter study investigates the role of psychotherapy in BPD

A French multicenter study headed by Jean Cottraux (Lyon) has investigated the role of psychotherapy in borderline personality disorder.

22 Sep 2009

A 2,000-mile scooter journey to raise cystic fibrosis awareness

Emily Schaller, a 27-year-old drummer with cystic fibrosis (CF), begins a 2,000-mile journey today aboard a Vespa scooter -- riding from Chicago to Burbank, California, in her quest to get on "The Ellen DeGeneres Show."

22 Sep 2009

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

CANCER RESEARCH UK is set to extend its drug discovery effort by investing up to £16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer Research in Manchester and the Beatson Institute for Cancer Research in Glasgow.

22 Sep 2009

Switch programme offers promise for use in youth obesity prevention

The SwitchTM programme, 'Switch what you Do, View, and Chew', has been shown to be capable of promoting children's fruit and vegetable consumption and lowering 'screen time'. Researchers writing in the open access journal BMC Medicine tested the programme and report that it offers promise for use in youth obesity prevention.

22 Sep 2009

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.

22 Sep 2009

Hormone therapy for treating prostate cancer is linked to heart problems

Berlin, Germany: New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others.

22 Sep 2009

Breast Cancer Action launches "Milking Cancer" campaign against Eli Lilly

Breast Cancer Action (BCA), known as the watchdog of the breast cancer movement, today announced the launch of their "Milking Cancer" campaign challenging the pharmaceutical giant Eli Lilly to stop manufacturing rBGH. rBGH (recombinant bovine growth hormone, also known as rBST) has long been linked to cancer.

22 Sep 2009

Comprehensive and practical overview of psoriasis

Treatments for psoriasis often present a therapeutic challenge to physicians because, besides affecting the skin, psoriasis may be associated with various comorbidities (for instance, depression, psoriatic arthritis, Crohn's disease and, in severe psoriasis, metabolic syndrome and cardiovascular diseases).

22 Sep 2009

Austin Retina partners with MVRF to sponsor SupportSight seminar

Austin Retina Associates has joined with the Macula Vision Research Foundation (MVRF) to sponsor a SupportSight seminar in Austin on October 3rd. SupportSight is the national series of educational seminars for people affected by macular degeneration and for those who would like to learn more about this disease affecting more than 25 million people in this country.

22 Sep 2009

Event to address rheumatoid arthritis

26 men and women with RA from across europe honoured as they share their inspirational stories. Actress, artist and activist Jane Seymour will host the first My Day for RA European event in Barcelona, Spain this evening to recognise the daily challenges, hopes and achievements of people living with rheumatoid arthritis (RA).

22 Sep 2009

Smoking bans result in consistent decline in heart attack rates: Study

A consistent decline in heart attack rates following the implementation of smoking bansStrongly enforced legislation to restrict smoking produces rapid and substantial reductions in community rates of heart attack, according to a meta-analysis published today in Circulation, the journal of the American Heart Association.

22 Sep 2009

National Standards Report on ASD treatments released by National Autism Center

The National Autism Center, a nonprofit organization dedicated to serving individuals with Autism Spectrum Disorders (ASD), today released its National Standards Report, the most comprehensive analysis of treatments for children and adolescents with ASD ever published.

22 Sep 2009

NicOx announces publication of blood pressure results from the phase 3 study of naproxcinod

NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).

22 Sep 2009

UAB's researchers find early indicators for Alzheimer's disease

Inability to handle financial transactions or manage money may be an early indicator that a person with mild memory problems soon is likely to develop Alzheimer's disease, according to new research from the University of Alabama at Birmingham (UAB) Alzheimer's Disease Center, part of the Department of Neurology.

22 Sep 2009

Veterans Healing Initiative formed for veterans suffering from PTSD

The Veterans Healing Initiative (VHI) has been formed in response to the dramatic increase of Substance Abuse (SA) and co-occurring mental health disorders among U.S. Veterans. Formed by Margaret Stone and James L. Abernathy, VHI's core mission is to raise funds for veterans who need treatment for Addiction and Post Traumatic Stress Disorder (PTSD) and help them begin to heal the war within.

22 Sep 2009

Late diagnosis of bipolar disorder in children and adults

75% of the cases of paediatric bipolar disorder are diagnosed late - up to 18 months - due to the symptoms manifesting themselves in a different manner depending on whether the patient is a child or adult. Moreover, 25% of sufferers have a delay in their medical diagnoses of up to three years and four months, according to a study by the Department of Psychiatry and Medical Psychology at the University Hospital of Navarra, in collaboration with the Paediatric Psychopharmacology Unit at the l Massachusetts General Hospital at Harvard University (Boston, United States).

22 Sep 2009